See other companies on Welcome to the Jungle
Core Biogenesis
Scalable bioproduction platform
- 1-20 employees
- B2B
- Sustainability
- Biology
- Environmental
- Gare, Paris, IDF
Jump to section
Company mission
To build the world's most scalable bioproduction platform.
Our take
Growth factors are molecules used in the clean meat and cell therapy industries. They have two primary applications, cell therapy for neurodegenerative diseases or cancers and the development of cultivated protein.
While costs of producing cell-based meats have fallen over the years, such as cultivated food tech pioneer Mosa Meat’s milestone of slashing costs of its growth medium by 88-fold, growth factors remain a costly ingredient that is a roadblock to mass production and commercialisation.
Core Biogenesis' method of large-scale production of growth factors enables them to lower costs significantly, which could make cultivated proteins more affordable and accessible when they get to market. The company has already secured around 30 confidential clients, including large pharmaceuticals and cultivated protein companies, who are interested in purchasing the firm’s growth factors.
Freddie
Company Specialist at Welcome to the Jungle
Funding (last 2 of 3 rounds)
Mar 2022
$10.6m
SERIES A
Mar 2022
$2m
GRANT
Total funding: $15.3m
This company has top investors
Leadership
Alexandre Reeber
(Founder)Experience as a Research Assistant at the University of Cambridge in the bioelectronics laboratory. Co-founded Core Biogenesis in 2020.